Knowledge Hub
Deep dives for pharma professionals
Research, innovation and market-trend explainers — the context behind the headlines, written for people who work in the industry.
146 articles in the hub
ResearchExploring Peptide-Based Innovations in Dermatology Research
Dermal research peptides show promise in collagen repair, host defense, and scaffold design for skin regeneration studies.
Team Pharma NowOct 04, 2025
ResearchOne-Step LNP Characterization: The GeneVecto Advantage
One-step CE–TDA analytics give absolute size and encapsulation efficiency, streamlining LNP programs from R&D to GMP.
Viktoria EnkmannSep 17, 2025
InnovationNet-Zero Pharma Is a Myth Without Global Alignment on Scope 3 Emissions
Pharma’s net-zero promises hide deeper gaps. Scope 3 emissions and pollution reveal why true sustainability remains elusive.
Thaddeus Anim-SomuahAug 31, 2025
ResearchHow Paper Chromatography Works: Capillary Action and Solvent Separation Explained
Uncover how paper chromatography uses capillary action and solvent separation for reliable pharma R&D, QA, and QC analysis.
Ravindra WarangAug 26, 2025
ResearchSolving Complex Analytical Challenges: A Practical Guide for Choosing RP vs. HILIC vs. Normal Phase
A practical guide to selecting the right column and separation mode for polar analytes in chromatography.
Mrudula KulkarniAug 16, 2025
ResearchUnderstanding FDA Form 483 Observations (and How to Respond)
Understand FDA Form 483, common violations, and how to respond effectively to prevent costly enforcement actions and warning letters.
Ravindra WarangAug 13, 2025
InnovationPreventing FDA Warning Letters - Building a Compliance-First Culture
Learn how a compliance - first culture, proactive audits, and strong training programs can help you avoid costly FDA warning letters.
Ravindra WarangAug 12, 2025
ResearchReal-World Examples of FDA Warning Letters (and What They Teach Us)
Explore real FDA warning letter cases and the compliance lessons they teach to help your business prevent costly violations.
Ravindra WarangAug 12, 2025
ResearchHow to Write an Effective FDA Warning Letter Response
Follow this proven process to address FDA warning letters—meet deadlines, fix violations, and maintain compliance with confidence.
Ravindra WarangAug 12, 2025
ResearchCreating Visibility for Indian Research: From Output to Global Influence
India needs a national publishing strategy to boost global impact, credibility, and equity in research.
Dr. Prashant MishraAug 11, 2025
Research5 Most Common Reasons for FDA Warning Letters (and How to Avoid Them)
Avoid costly FDA warning letters by knowing the top violations—GMP, mislabeling, reporting failures and how to stay fully compliant.
Ravindra WarangAug 11, 2025
InnovationDigitization in Pharma - Risk or Opportunity?
A deep dive into pharma’s digitization journey—challenges, progress, and what the future demands.
Chandrashekhar RaoAug 05, 2025